Related Experiment Video
Updated: Jun 12, 2026
04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Beta-like hippocampal network activity is differentially affected by amyloid beta peptides
Alvaro Adaya-Villanueva1, Benito Ordaz, Hugo Balleza-Tapia
1Departamento de Farmacobiología, Cinvestav-Sede Sur, México, D.F., México.
Peptides
|June 19, 2010
Summary
Different amyloid beta peptides differentially impact brain network activity. Monomeric and oligomeric forms affect specific oscillations, suggesting targeted mechanisms in Alzheimer's disease (AD) rather than a general inhibitory effect.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alzheimer disease (AD) is linked to altered neuronal network oscillations and cognitive deficits.
- Amyloid beta (Abeta) peptides differentially affect hippocampal network activities, impacting theta and gamma oscillations but not sharp waves/ripples.
Purpose of the Study:
- To investigate the differential effects of various amyloid beta (Abeta) peptides on beta-like oscillatory patterns in the hippocampus.
- To determine if monomeric Abeta(25-35) and oligomeric Abeta(1-42) exhibit distinct impacts on kainate- and potassium-induced oscillations.
Main Methods:
- Evoked beta-like oscillations in hippocampal slices using kainate and increased extracellular potassium.
- Applied different concentrations of fresh dissolved Abeta(25-35) (monomeric) and oligomerized Abeta(1-42).
- Monitored and analyzed the effects of Abeta peptides on the oscillatory network activity.
Main Results:
- Both monomeric Abeta(25-35) and oligomeric Abeta(1-42) affected kainate-induced oscillations in a concentration-dependent manner.
- Oligomeric Abeta(1-42) reduced potassium-induced oscillations, while monomeric Abeta(25-35) had no significant effect.
- These findings indicate differential modulation of specific neuronal network activities by distinct Abeta peptide forms.
Conclusions:
- Different amyloid beta peptides selectively alter specific cellular mechanisms underlying neuronal network activity.
- The observed effects suggest that Abeta's impact on brain function in Alzheimer's disease is not a generalized inhibition but rather targets specific pathways.
